Abstract:Bacteriophages (phages) are viruses that infect bacteria with species- and strain-level specificity and are the most abundant biological entities across all known ecosystems. Within bacterial communities, such as those found in the gut microbiota, phages are implicated in regulating microbiota population dynamics and driving bacterial evolution. There has been renewed interest in phage research in the last decade, in part due to the host-specific killing capabilities of lytic phages, which offer a promising tool to counter the increasing threat of antimicrobial resistant bacteria. Furthermore, recent studies demonstrating that phages adhere to intestinal mucus suggest they may have a protective role in preventing bacterial invasion into the underlying epithelium. Importantly, like bacterial microbiomes, disrupted phageomes have been associated with worsened outcomes in diseases such as inflammatory bowel disease. Previous studies have demonstrated that phages can modulate the microbiome of animals and humans through fecal filtrate transplants, benefiting the host's health. With this recent wave of research comes the necessity to establish and standardize protocols for studying phages in the context of the gut microbiome. This protocol provides a set of procedures to study isolated T4 phages and their bacterial host, Escherichia coli, in the context of the murine gastrointestinal tract. The methods described here outline how to start from a phage lysate, administer it to mice and assess effects on bacterial host and phage levels. This protocol can be modified and applied to other phage-bacterial pairs and provides a starting point for studying host-phage dynamics in vivo.

Editing of a Specific Strain of Escherichia coli in the Mouse Gut Using Native Phages

Knockout of a labeled strain of Escherichia coli in the mouse gut using native phages

Phages to the rescue: in situ editing of the gut microbiota

In situ targeted base editing of bacteria in the mouse gut

Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

Bacteriophages allow selective depletion of gut bacteria to produce a targeted-bacterium-depleted mouse model

Precise microbiome engineering using natural and synthetic bacteriophages targeting an artificial bacterial consortium

Genetic editing of the virulence gene of Escherichia coli using the CRISPR system.

High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing

Targeted-Bacterium-Depleted (TBD) Mice Model and its Validation Using <i>Escherichia Coli</i> Phage T7 in a Microbiota-Gut-Brain Axis Study

Characterization the gene editing with miniature nucleases TnpB, IscB and enIscB in Escherichia coli strains

Awakening prime editing for precision engineering of probiotic Escherichia coli Nissle 1917

Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo

Multigene Editing in the Escherichia coli Genome via the CRISPR-Cas9 System

BacPE: a versatile prime-editing platform in bacteria by inhibiting DNA exonucleases

Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators

Combining CRISPR-Cpf1 and Recombineering Facilitates Fast and Efficient Genome Editing in Escherichia coli

Developing the <i>Limosilactobacillus reuteri</i> Chassis through an Endogenous Programmable Endonuclease-Based Genome Editing Tool

Targeted-Bacterium-Depleted (TBD) Mice Model and its Validation Using Escherichia Coli Phage T7 in a Microbiota-Gut-Brain Axis Study